THIS INFORMATION IS INTENDED FOR
UK HEALTHCARE PROFESSIONALS ONLY.

ARE YOU A UK HEALTHCARE PROFESSIONAL?

YES, I AM A UK HEALTHCARE PROFESSIONAL

NO, I AM NOT A UK HEALTHCARE PROFESSIONAL

Here are some helpful links if you'd like to find out more about Parkinson's Disease. Please note, by clicking on the links below you are about to leave an Abbvie website. You will be redirected to an independent website for which AbbVie assumes no liability.

NHS

Parkinson’s UK website

For further information on Duodopa® or other medicines, please use the link below to access the electronic Medicines Compendium (eMC)

eMC

Duodopa® Resource Centre

Menu

Duodopa is indicated for advanced levodopa-responsive Parkinson's disease with severe motor fluctuations and hyper/dyskinesia when available combinations of Parkinson medicinal products have not given satisfactory results.

For Healthcare Professionals only

Helping you manage
your patients on Duodopa®

Explore the Duodopa® Treatment Process Resources

The resources available on this website are divided into Treatment Process sections, helping you to access them quickly whenever you need them.
You can review all of the resources on the Duodopa® Treatment Process, or just examine those resources related to a Treatment Process section of your choice.

Select any of the Duodopa® Treatment Process links below to begin browsing:

Complete Duodopa® Treatment Process

A complete overview of the resources available throughout the Duodopa® Treatment Process.

Patient Identification

Information on criteria for identifying patients for whom advanced ("post-oral") therapies may be appropriate.

Referral

Resources to help start the process, once you have identified a patient for whom Duodopa® may be approipriate.

Pre-admission

Information for HCPs, patients and carers on what to expect from treatment with Duodopa®.

On-boarding

This section contains information for the multi-disciplinary team to support successful initiation of Duodopa®.

Aftercare

Information on ongoing care for the Duodopa® patient post-discharge, and where to get support.


Adverse Event Reporting

Report Adverse Events

Adverse events should be reported. Reporting forms and information can be found at:

www.mhra.gov.uk/yellowcard.

Adverse events should also be reported to AbbVie
on 01628 774933

By continuing to use this website, you agree to the use of cookies. You can find out more by following this link Accept cookies